HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
RIN2
Ras and Rab interactor 2
Chromosome 20 Β· 20p11.23
NCBI Gene: 54453Ensembl: ENSG00000132669.15HGNC: HGNC:18750UniProt: A1A4T0
36PubMed Papers
21Diseases
0Drugs
18Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of endothelial cell-matrix adhesionpositive regulation of endothelial cell migrationpositive regulation of vasculogenesisguanyl-nucleotide exchange factor activityRIN2 syndromeMACS syndromeAbnormality of the skeletal systemliver disease
✦AI Summary

RIN2 (Ras and Rab interactor 2) is a guanine nucleotide exchange factor (GEF) that activates the small GTPase Rab5 to regulate endocytic trafficking 1. In endothelial cells, the RIN2/Rab5C complex prevents lysosomal degradation of internalized VEGFR2, maintaining receptor signaling through ERK and PI3K pathways essential for angiogenic tip cell specification and sprouting 2. RIN2 also functions as an effector of R-Ras, promoting selective endocytosis of active Ξ²1 integrins and activating Rac1-dependent cell adhesion via TIAM1 signaling 1. Additionally, insulin stimulation induces pro-reductive shifts in RIN2 cysteine modifications that modulate insulin signal transduction in skeletal muscle 3. Biallelic RIN2 mutations cause RIN2 syndrome (formerly MACS syndrome), an autosomal recessive connective tissue disorder characterized by progressive facial coarsening, sparse hair, skin laxity, scoliosis, joint hypermobility, and dental abnormalities 45. The disorder results from impaired intracellular trafficking due to RIN2 deficiency, with ultrastructural collagen fibril abnormalities and organellar dysfunction in fibroblasts 6. Expanding clinical features include leukoencephalopathy, bronchiectasis, hypergonadotropic hypogonadism, and cervical vertebral fusion 75.

Sources cited
1
RIN2/Rab5C prevents VEGFR2 lysosomal degradation and maintains ERK/PI3K signaling and angiogenic tip cell identity
PMID: 33983539
2
RIN2 functions as Rab5 GEF and R-Ras effector; promotes Ξ²1 integrin endocytosis and Rac1-dependent cell adhesion
PMID: 22825554
3
RIN2 syndrome characterized by dysmorphic features, cutis laxa, scoliosis, and expanded clinical phenotype
PMID: 27277385
4
RIN2 syndrome presents with macrocephaly, alopecia, cutis laxa, scoliosis, plus bronchiectasis and hypergonadotropic hypogonadism
PMID: 24449201
5
Insulin stimulation induces pro-reductive shifts in RIN2 Cys416 modifications modulating insulin signaling
PMID: 40194326
6
RIN2 syndrome associated with leukoencephalopathy and white matter abnormalities
PMID: 30769224
7
RIN2 deficiency causes impaired endocytic trafficking, collagen fibril abnormalities, and organellar dysfunction in connective tissue
PMID: 20424861
Disease Associationsβ“˜21
RIN2 syndromeOpen Targets
0.68Moderate
MACS syndromeOpen Targets
0.59Moderate
Abnormality of the skeletal systemOpen Targets
0.54Moderate
liver diseaseOpen Targets
0.37Weak
HypoventilationOpen Targets
0.32Weak
osteoarthritisOpen Targets
0.30Weak
glomerulonephritisOpen Targets
0.29Weak
chondromalaciaOpen Targets
0.25Weak
enteritisOpen Targets
0.24Weak
Benign Thyroid Gland NeoplasmOpen Targets
0.23Weak
ShockOpen Targets
0.23Weak
migraine disorderOpen Targets
0.22Weak
cataractOpen Targets
0.21Weak
alcohol drinkingOpen Targets
0.21Weak
genetic disorderOpen Targets
0.19Weak
lens diseaseOpen Targets
0.18Weak
placenta praeviaOpen Targets
0.16Weak
brain aneurysmOpen Targets
0.15Weak
Cerebral degenerationOpen Targets
0.14Weak
senile cataractOpen Targets
0.13Weak
MACS syndromeUniProt
Pathogenic Variants18
NM_018993.4(RIN2):c.183del (p.Tyr62fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 62
NM_018993.4(RIN2):c.46del (p.Ser16fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 16
NM_018993.4(RIN2):c.1731dup (p.Ile578fs)Pathogenic
RIN2 syndrome|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 578
NM_018993.4(RIN2):c.462C>G (p.Tyr154Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 154
NM_018993.4(RIN2):c.1731del (p.Ile578fs)Pathogenic
RIN2 syndrome|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 578
NM_018993.4(RIN2):c.814_826del (p.Ile272fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 272
NM_018993.4(RIN2):c.277del (p.Thr93fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 93
NM_018993.4(RIN2):c.921_922insG (p.Pro308fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 308
NM_018993.4(RIN2):c.2272C>T (p.Arg758Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 758
NM_018993.4(RIN2):c.1916dup (p.Val641fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 641
NM_018993.4(RIN2):c.537-2A>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_018993.4(RIN2):c.2069-1G>TLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_018993.4(RIN2):c.97C>T (p.Gln33Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 33
NM_018993.4(RIN2):c.131del (p.Asn44fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 44
NM_018993.4(RIN2):c.277_278dup (p.His94fs)Likely pathogenic
RIN2 syndrome
β˜…β˜†β˜†β˜†2019β†’ Residue 94
NM_018993.4(RIN2):c.2104dup (p.Leu702fs)Likely pathogenic
RIN2 syndrome
β˜…β˜†β˜†β˜†β†’ Residue 702
NM_018993.4(RIN2):c.351+2T>ALikely pathogenic
RIN2-related disorder
β˜†β˜†β˜†β˜†2024
NM_018993.4(RIN2):c.1914_1915del (p.Glu638fs)Pathogenic
RIN2 syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 638
View on ClinVar β†—
Related Genes
RAB5AProtein interaction97%RAB5BProtein interaction94%FBLN5Protein interaction78%GFUSShared pathway29%RRASShared pathway27%GDI2Shared pathway25%
Tissue Expression6 tissues
Heart
100%
Bone Marrow
87%
Lung
81%
Ovary
43%
Brain
43%
Liver
21%
Gene Interaction Network
Click a node to explore
RIN2RAB5ARAB5BFBLN5GFUSRRASGDI2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q8WYP3
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.64LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.48 [0.36–0.64]
RankingsWhere RIN2 stands among ~20K protein-coding genes
  • #10,852of 20,598
    Most Researched36
  • #2,300of 5,498
    Most Pathogenic Variants18
  • #4,541of 17,882
    Most Constrained (LOEUF)0.64
Genes detectedRIN2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The endosomalΒ RIN2/Rab5C machineryΒ prevents VEGFR2 degradation to control gene expression and tip cell identity during angiogenesis.
PMID: 33983539
Angiogenesis Β· 2021
1.00
2
RIN2 syndrome: Expanding the clinical phenotype.
PMID: 27277385
Am J Med Genet A Β· 2016
0.90
3
Newly described clinical features in two siblings with MACS syndrome and a novel mutation in RIN2.
PMID: 24449201
Am J Med Genet A Β· 2014
0.80
4
Revisiting insulin-stimulated hydrogen peroxide dynamics reveals a cytosolic reductive shift in skeletal muscle.
PMID: 40194326
Redox Biol Β· 2025
0.70
5
Leukoencephalopathy in RIN2 syndrome: Novel mutation and expansion of clinical spectrum.
PMID: 30769224
Eur J Med Genet Β· 2020
0.60